Dec. 21-23 Quick Takes: readouts for Genentech, Rhythm, ChemoCentryx and BMS

By BioCentury Staff

Dec 23, 2020 | 10:58 PM GMT

Genentech’s faricimab meets in Phase III diabetic macular edema trials
The Genentech Inc. unit